BACKGROUND: The introduction of technique of radiofrequency (RF) catheter ablation in 1990, has revolutionized management of different types of paroxysmal supraventricular tachycardia (PSVT). In spite of higher success rate, there were reported recurrences among different types of SVT. The aim of this study was to report the efficacy of RF ablation, its complications, recurrence rate and its predictors. METHODS: The material of this study (our 3rd registry) included patients who underwent electrophysiological study (EPS) and radiofrequency ablation of their supraventricular tachycardia in the past 5 years, starting from January 2002 to January 2007 at The Critical Care Medicine Department, Cairo University. RESULTS: Out of 400 pts studied, 381 (95%) had been subjected to radiofrequency ablation (RF) ablation while the remaining 19 pts (4.7%) refused ablation for fear of possible complications. Out of the 381 pts, 366 (96%) had their target tachycardia successfully terminated, from them 26 pts (7%) experienced recurrence after having successful RF ablation. Nine pts (34.6%) of total recurrence was reported in pts with AVNRT, 7 pts (26.9%) of total recurrence was reported in pts with AVRT utilizing septal accessory pathway (Rt AS and /or Rt PS AP), 4 pts (15.4%) was reported in pts with double AP, 2 pts (7.7%) of total recurrence was reported in pts with AFl, one pt (3.8%) of total recurrence was reported in cases of AT. Redo ablation have been carried out successfully in 25 pts (96.2%), and one pt (3.8%) refused ablation for fear of possible complications. CONCLUSIONS: Although electrophysiological study and RF ablation eliminated different types of SVT. However, there may be increased incidence of recurrence among pts with AVNRT and AVRT utilizing concealed septal AP and multiple APs secondary to the complexity of AVN physiology, the critical location of septal AP, the clinical expertise, and poor electrophysiological criteria for good procedural success.
BACKGROUND: The introduction of technique of radiofrequency (RF) catheter ablation in 1990, has revolutionized management of different types of paroxysmal supraventricular tachycardia (PSVT). In spite of higher success rate, there were reported recurrences among different types of SVT. The aim of this study was to report the efficacy of RF ablation, its complications, recurrence rate and its predictors. METHODS: The material of this study (our 3rd registry) included patients who underwent electrophysiological study (EPS) and radiofrequency ablation of their supraventricular tachycardia in the past 5 years, starting from January 2002 to January 2007 at The Critical Care Medicine Department, Cairo University. RESULTS: Out of 400 pts studied, 381 (95%) had been subjected to radiofrequency ablation (RF) ablation while the remaining 19 pts (4.7%) refused ablation for fear of possible complications. Out of the 381 pts, 366 (96%) had their target tachycardia successfully terminated, from them 26 pts (7%) experienced recurrence after having successful RF ablation. Nine pts (34.6%) of total recurrence was reported in pts with AVNRT, 7 pts (26.9%) of total recurrence was reported in pts with AVRT utilizing septal accessory pathway (Rt AS and /or Rt PS AP), 4 pts (15.4%) was reported in pts with double AP, 2 pts (7.7%) of total recurrence was reported in pts with AFl, one pt (3.8%) of total recurrence was reported in cases of AT. Redo ablation have been carried out successfully in 25 pts (96.2%), and one pt (3.8%) refused ablation for fear of possible complications. CONCLUSIONS: Although electrophysiological study and RF ablation eliminated different types of SVT. However, there may be increased incidence of recurrence among pts with AVNRT and AVRT utilizing concealed septal AP and multiple APs secondary to the complexity of AVN physiology, the critical location of septal AP, the clinical expertise, and poor electrophysiological criteria for good procedural success.
Authors: Carina Blomström-Lundqvist; Melvin M Scheinman; Etienne M Aliot; Joseph S Alpert; Hugh Calkins; A John Camm; W Barton Campbell; David E Haines; Karl H Kuck; Bruce B Lerman; D Douglas Miller; Charlie Willard Shaeffer; William G Stevenson; Gordon F Tomaselli; Elliott M Antman; Sidney C Smith; Joseph S Alpert; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs; Richard O Russell; Silvia G Priori; Jean Jacques Blanc; Andzrej Budaj; Enrique Fernandez Burgos; Martin Cowie; Jaap Willem Deckers; Maria Angeles Alonso Garcia; Werner W Klein; John Lekakis; Bertil Lindahl; Gianfranco Mazzotta; João Carlos Araujo Morais; Ali Oto; Otto Smiseth; Hans Joachim Trappe Journal: J Am Coll Cardiol Date: 2003-10-15 Impact factor: 24.094
Authors: George F Van Hare; Harold Javitz; Dorit Carmelli; J Philip Saul; Ronn E Tanel; Peter S Fischbach; Ronald J Kanter; Michael Schaffer; Ann Dunnigan; Steven Colan; Gerald Serwer Journal: J Cardiovasc Electrophysiol Date: 2004-07
Authors: Hendrik Bonnemeier; Gert Richardt; Jürgen Potratz; Uwe K H Wiegand; Axel Brandes; Nina Kluge; Hugo A Katus Journal: J Cardiovasc Electrophysiol Date: 2003-08